Press & News

In The News

Inc. Names Avalon #4 Among America’s Fastest Growing Private Companies

Benefit ManagementClinical Insights

Avalon Healthcare Solutions is pleased to announce it has achieved the No. 4 ranking on Inc.s annual Inc. 500 list, the most prestigious ranking of the nations fastest-growing private companies. The list represents a unique look at the most successful companies within the American economys most dynamic segmentits independent small businesses. Intuit, Zappos, Under Armour, Microsoft, Patagonia, and many other well-known names gained their first national exposure as honorees on the Inc. 5000.

The team at Avalon Healthcare Solutions is honored to rank so highly on this prestigious list of fast-growing private companies, said Bill Kerr, MD, Avalons Chief Executive Officer, Our growth over the past three years is a direct result of the dedication of our employees as we work to deliver on the triple aim in healthcare of improved cost, quality, and access through innovative laboratory benefit management technology. Complete results of the Inc. 5000, including company profiles and an interactive database that can be sorted by industry, region, and other criteria, can be found at www.inc.com/inc5000. The top 500 companies are also being featured in the September issue of Inc., available on newsstands August 18.

About Avalon Healthcare Solutions

Avalon is a healthcare information technology and specialty benefit management company focused on laboratory testing. Avalon provides a comprehensive program to facilitate management of all outpatient laboratory services across all providers, including independent, physician office, and hospital-based laboratories. Using an independent Clinical Advisory Board, Avalon has developed a suite of science-based laboratory policies addressing all testing categories. The majority of these policies, reflecting high-volume, low-cost services, are administered through proprietary, automated technology, typically saving health plans 7 to 12 percent on outpatient laboratory spend.